A recently opened study is recruiting unaffected BRCA1/2 mutation carriers to explore any relationship between TL (plus a variety of metabolic and lifestyle factors) and breast cancer risk, and will avoid the compounding factors such as treatment effects which may bias the retrospective studies [31]. Here, BRCA1 is linked to breast carcinoma.